Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.53 EUR | -3.80% | +8.82% | -3.44% |
May. 14 | Transcript : Innate Pharma S.A., Q1 2024 Earnings Call, May 14, 2024 | |
Apr. 15 | Sanofi: progress in hematology trial | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.44% | 231M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+48.54% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- IPH Stock
- News Innate Pharma
- Innate Pharma Says Trials of Lymphoma Therapy Placed on Partial Clinical Hold After Patient Death